1. MAPK/ERK Pathway Stem Cell/Wnt PI3K/Akt/mTOR Apoptosis Immunology/Inflammation
  2. ERK GSK-3 Apoptosis Caspase COX
  3. α-Amyrin

α-Amyrin  (Synonyms: α-アミリン)

製品番号: HY-N8423 純度: 99.99%
COA 取扱説明書 Technical Support

α-Amyrin is a pentacyclic triterpenoid compound with oral activity. α-Amyrin activates the ERK and GSK-3β signaling pathways. α-Amyrin can inhibit cancer cells proliferation and induce apoptosis. α-Amyrin shows anti-bacterial and anti-inflammation activity. α-Amyrin can reduce blood glucose level. α-Amyrin can be used for the researches of cancer, infection, inflammation, metabolic disease and neurological disease, such as breast cancer, Streptococcus oralis infection, skin inflammation and diabetes.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

α-Amyrin

α-Amyrin 構造式

CAS 番号 : 638-95-9

容量 価格(税別) 在庫状況 数量
1 mg $80 在庫あり
5 mg $195 在庫あり
10 mg $320 在庫あり
50 mg   お問い合わせ  
100 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 1 publication(s) in Google Scholar

Other Forms of α-Amyrin:

Top Publications Citing Use of Products
  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

α-Amyrin is a pentacyclic triterpenoid compound with oral activity. α-Amyrin activates the ERK and GSK-3β signaling pathways. α-Amyrin can inhibit cancer cells proliferation and induce apoptosis. α-Amyrin shows anti-bacterial and anti-inflammation activity. α-Amyrin can reduce blood glucose level. α-Amyrin can be used for the researches of cancer, infection, inflammation, metabolic disease and neurological disease, such as breast cancer, Streptococcus oralis infection, skin inflammation and diabetes[1][2][3][4][5][6][7].

IC50 & Target[1]

GSK-3β

 

Caspase 3

 

COX-2

 

Cellular Effect
Cell Line Type Value Description References
A2780 IC50
20.6 6
Compound: alpha-amyrin
Cytotoxicity against human A2780 cells
Cytotoxicity against human A2780 cells
[PMID: 15165160]
A2780 IC50
20.6 6
Compound: alpha-amyrin
Cytotoxicity against human A2780 cells
Cytotoxicity against human A2780 cells
[PMID: 15165160]
A549 GI50
10.54 3
Compound: 58
Cytotoxicity against human A549 cells after 48 hrs by WST8 assay
Cytotoxicity against human A549 cells after 48 hrs by WST8 assay
[PMID: 20371180]
A549 GI50
10.54 3
Compound: 58
Cytotoxicity against human A549 cells after 48 hrs by WST8 assay
Cytotoxicity against human A549 cells after 48 hrs by WST8 assay
[PMID: 20371180]
A549 GI50
10.54 3
Compound: 58
Cytotoxicity against human A549 cells after 48 hrs by WST8 assay
Cytotoxicity against human A549 cells after 48 hrs by WST8 assay
[PMID: 20371180]
B16 ED50
> 50 3
Compound: 19
Induction of melanogenesis in mouse B16 2F2 cells assessed as intracellular melanin content after 3 days
Induction of melanogenesis in mouse B16 2F2 cells assessed as intracellular melanin content after 3 days
[PMID: 12027734]
B16 ED50
> 50 3
Compound: 19
Induction of melanogenesis in mouse B16 2F2 cells assessed as intracellular melanin content after 3 days
Induction of melanogenesis in mouse B16 2F2 cells assessed as intracellular melanin content after 3 days
[PMID: 12027734]
B16 IC50
50 3
Compound: 19
Growth inhibition of mouse B16 2F2 cells after 3 days
Growth inhibition of mouse B16 2F2 cells after 3 days
[PMID: 12027734]
B16 ED50
>50 3
Compound: 19
Induction of melanogenesis in mouse B16 2F2 cells assessed as intracellular melanin content after 3 days
Induction of melanogenesis in mouse B16 2F2 cells assessed as intracellular melanin content after 3 days
[PMID: 12027734]
B16 IC50
50 3
Compound: 19
Growth inhibition of mouse B16 2F2 cells after 3 days
Growth inhibition of mouse B16 2F2 cells after 3 days
[PMID: 12027734]
CHO EC50
> 10 3
Compound: Alpha-amyrin
Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay
Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay
[PMID: 19911773]
B16 IC50
50 3
Compound: 19
Growth inhibition of mouse B16 2F2 cells after 3 days
Growth inhibition of mouse B16 2F2 cells after 3 days
[PMID: 12027734]
CHO EC50
> 10 3
Compound: Alpha-amyrin
Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay
Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay
[PMID: 19911773]
CHO EC50
>10 3
Compound: Alpha-amyrin
Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay
Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay
[PMID: 19911773]
COS-1 EC50
0 3
Compound: Alpha-amyrin
Agonist activity at human FXR expressed in COS1 cells by luciferase reporter gene assay
Agonist activity at human FXR expressed in COS1 cells by luciferase reporter gene assay
[PMID: 19911773]
HepG2 IC50
220 3
Compound: 8
Cytotoxicity against human Hep G2 cells after 48 hrs by WST-8 assay
Cytotoxicity against human Hep G2 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
HepG2 IC50
> 100 3
Compound: 8
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
HepG2 IC50
220 3
Compound: 8
Cytotoxicity against human Hep G2 cells after 48 hrs by WST-8 assay
Cytotoxicity against human Hep G2 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
HepG2 IC50
> 100 3
Compound: 8
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
HepG2 IC50
>100 3
Compound: 8
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
HepG2 IC50
220 3
Compound: 8
Cytotoxicity against human Hep G2 cells after 48 hrs by WST-8 assay
Cytotoxicity against human Hep G2 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
J774 IC50
128.5 3
Compound: 1
Cytotoxicity against mouse J774 cells by alamar blue assay
Cytotoxicity against mouse J774 cells by alamar blue assay
[PMID: 17637068]
J774 IC50
128.5 3
Compound: 1
Cytotoxicity against mouse J774 cells by alamar blue assay
Cytotoxicity against mouse J774 cells by alamar blue assay
[PMID: 17637068]
KB IC50
>100 3
Compound: 8
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
J774 IC50
128.5 3
Compound: 1
Cytotoxicity against mouse J774 cells by alamar blue assay
Cytotoxicity against mouse J774 cells by alamar blue assay
[PMID: 17637068]
KB IC50
> 100 3
Compound: 8
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
Lu1 IC50
>100 3
Compound: 8
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
KB IC50
> 100 3
Compound: 8
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
Lu1 IC50
> 100 3
Compound: 8
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
MCF7 IC50
>100 3
Compound: 8
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
MCF7 IC50
> 100 3
Compound: 8
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
PANC-1 GI50
12.8 3
Compound: 58
Cytotoxicity against human PANC1 cells after 48 hrs by WST8 assay
Cytotoxicity against human PANC1 cells after 48 hrs by WST8 assay
[PMID: 20371180]
Lu1 IC50
> 100 3
Compound: 8
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human Lu1 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
PANC-1 GI50
12.8 3
Compound: 58
Cytotoxicity against human PANC1 cells after 48 hrs by WST8 assay
Cytotoxicity against human PANC1 cells after 48 hrs by WST8 assay
[PMID: 20371180]
MCF7 IC50
> 100 3
Compound: 8
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by neutral red assay
[PMID: 28318944]
PC-3 GI50
7.66 3
Compound: 58
Cytotoxicity against human PC3 cells after 48 hrs by WST8 assay
Cytotoxicity against human PC3 cells after 48 hrs by WST8 assay
[PMID: 20371180]
PC-3 GI50
7.66 3
Compound: 58
Cytotoxicity against human PC3 cells after 48 hrs by WST8 assay
Cytotoxicity against human PC3 cells after 48 hrs by WST8 assay
[PMID: 20371180]
PANC-1 GI50
12.8 3
Compound: 58
Cytotoxicity against human PANC1 cells after 48 hrs by WST8 assay
Cytotoxicity against human PANC1 cells after 48 hrs by WST8 assay
[PMID: 20371180]
SH-SY5Y EC50
>50 3
Compound: 37
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 1-methyl-4-phenylpyridinium ion-induced cell death after 48 hrs by MTT assay
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 1-methyl-4-phenylpyridinium ion-induced cell death after 48 hrs by MTT assay
[PMID: 27420919]
SH-SY5Y EC50
> 50 3
Compound: 37
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 1-methyl-4-phenylpyridinium ion-induced cell death after 48 hrs by MTT assay
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 1-methyl-4-phenylpyridinium ion-induced cell death after 48 hrs by MTT assay
[PMID: 27420919]
SH-SY5Y EC50
13.3 3
Compound: 37
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen glucose deprivation-induced cell death incubated for 16 hrs under hypoxic condition followed by incubation for 24 hrs under normoxic condition by MTT assay
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen glucose deprivation-induced cell death incubated for 16 hrs under hypoxic condition followed by incubation for 24 hrs under normoxic condition by MTT assay
[PMID: 27420919]
PC-3 GI50
7.66 3
Compound: 58
Cytotoxicity against human PC3 cells after 48 hrs by WST8 assay
Cytotoxicity against human PC3 cells after 48 hrs by WST8 assay
[PMID: 20371180]
SH-SY5Y EC50
13.3 3
Compound: 37
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen glucose deprivation-induced cell death incubated for 16 hrs under hypoxic condition followed by incubation for 24 hrs under normoxic condition by MTT assay
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen glucose deprivation-induced cell death incubated for 16 hrs under hypoxic condition followed by incubation for 24 hrs under normoxic condition by MTT assay
[PMID: 27420919]
SH-SY5Y EC50
13.3 3
Compound: 37
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen glucose deprivation-induced cell death incubated for 16 hrs under hypoxic condition followed by incubation for 24 hrs under normoxic condition by MTT assay
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen glucose deprivation-induced cell death incubated for 16 hrs under hypoxic condition followed by incubation for 24 hrs under normoxic condition by MTT assay
[PMID: 27420919]
WI-38 IC50
12.7 3
Compound: 8
Cytotoxicity against human WI 38 cells after 48 hrs by WST-8 assay
Cytotoxicity against human WI 38 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
WI-38 IC50
12.7 3
Compound: 8
Cytotoxicity against human WI 38 cells after 48 hrs by WST-8 assay
Cytotoxicity against human WI 38 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
SH-SY5Y EC50
> 50 3
Compound: 37
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 1-methyl-4-phenylpyridinium ion-induced cell death after 48 hrs by MTT assay
Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 1-methyl-4-phenylpyridinium ion-induced cell death after 48 hrs by MTT assay
[PMID: 27420919]
WI-38 VA13 IC50
>235 3
Compound: 8
Cytotoxicity against human VA13 cells after 48 hrs by WST-8 assay
Cytotoxicity against human VA13 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
WI-38 VA13 IC50
> 235 3
Compound: 8
Cytotoxicity against human VA13 cells after 48 hrs by WST-8 assay
Cytotoxicity against human VA13 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
WI-38 IC50
12.7 3
Compound: 8
Cytotoxicity against human WI 38 cells after 48 hrs by WST-8 assay
Cytotoxicity against human WI 38 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
WI-38 VA13 IC50
> 235 3
Compound: 8
Cytotoxicity against human VA13 cells after 48 hrs by WST-8 assay
Cytotoxicity against human VA13 cells after 48 hrs by WST-8 assay
[PMID: 15730243]
体外実験

α-Amyrin (10 μM, 24 h) induces AMPK and PPARδ/ γ-mediated GLUT4 translocation in C2C12 myoblasts[1].
α-Amyrin (acetate) (2.5-10 μg/mL, 0-72 h) inhibits proliferation and colony formation in MDA-MB-231 cells[6].
α-Amyrin (acetate) (5-10 μg/mL, 24 h) induces apoptosis and increases caspase-3 activity in MDA-MB-231 cells[6].
α-Amyrin (acetate) (10 μg/mL, 24 h) promotes the cleavage of Poly polymerase, increased E-cadherin, and inhibits vimentin and phosphorylated extracellular signal-regulated activation in MDA-MB-231 cells[6].
α-Amyrin (10-1000 μg/mL, 24 h) reduces percentage of viability of Streptococcus salivarius, Streptococcus sanguinis and Streptococcus oralis[7].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: C2C12 cells
Concentration: 10 μM
Incubation Time: 24 h
Result: Increased the mRNA and protein expression of PPARs, GLUT4 and FATP.

Apoptosis Analysis[2]

Cell Line: MDA-MB-231 cells
Concentration: 5 and 10 μg/mL
Incubation Time: 24 h
Result: Increased apoptotic cells.
Increased caspase-3 activity.
体内実験

α-Amyrin (50-200 mg/kg, p.o., once daily for 42 days) can reduce the survival rate of rats with metabolic syndrome induced by high fructose diet[2].
α-Amyrin (2-4 mg/kg, p.o.) improves cognitive dysfunction caused by low cholinergic neurotransmission in mice by activating ERK and GSK-3β signaling pathways[3].
α-Amyrin (acetate) (50 mg/kg, p.o., daily for 1-10 days) reduces the blood glucose level in diabetic rats[4].
α-Amyrin (0.1-1.0 mg/ear, topical application) inhibits inflammation in 12-O-tetradecanoylphorbol-acetate (TPA)-induced skin inflammation of mice[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: High-fructose diet (HFD)-induced metabolic syndrome in rats[2]
Dosage: 50, 100 and 200 mg/kg
Administration: Orally administration
Result: Decreased systolic blood pressure, plasma glucose, total cholesterol, and plasma triglycerides.
Attenuated hepatic oxidative stress as well as micro- and macrovesicular fatty changes in hepatocytes caused by HFD.
Animal Model: Scopolamine-Induced Memory Impairment Mice[3]
Dosage: 2 and 4 mg/kg
Administration: Orally administration
Result: Increased the expression levels of phosphorylated extracellular signal-regulated kinase 1/2 (pERK) and phosphorylated glycogen synthase kinase-3β (pGSK-3β).
Animal Model: 12-O-tetradecanoylphorbol-acetate (TPA)-induced skin inflammation of mice[5]
Dosage: 0.1, 0.3 and 1.0 mg/ear, topical application
Administration: Topically application
Result: Inhibited skin inflammation.
Reduced COX-2 levels and activation of NF-κB and MAPKs.
分子量

426.72

分子式

C30H50O

CAS 番号
Appearance

Solid

Color

White to off-white

SMILES

C[C@]12[C@]3(C([C@@]4([H])[C@@](CC3)(CC[C@H]([C@@H]4C)C)C)=CC[C@]1([H])[C@@]5([C@@](C(C)([C@H](CC5)O)C)([H])CC2)C)C

Structure Classification
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶剤 & 溶解度
体外: 

DMSO : 5 mg/mL (11.72 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Methanol : 1 mg/mL (2.34 mM; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.3435 mL 11.7173 mL 23.4346 mL
5 mM 0.4687 mL 2.3435 mL 4.6869 mL
10 mM 0.2343 mL 1.1717 mL 2.3435 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始)

C1

×
体積 (開始)

V1

=
濃度 (終了)

C2

×
体積 (終了)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
純度とドキュメンテーション

純度: 99.99%

参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
Methanol / DMSO 1 mM 2.3435 mL 11.7173 mL 23.4346 mL 58.5864 mL
DMSO 5 mM 0.4687 mL 2.3435 mL 4.6869 mL 11.7173 mL
10 mM 0.2343 mL 1.1717 mL 2.3435 mL 5.8586 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
α-Amyrin
製品番号:
HY-N8423
数量:
MCE 日本正規代理店: